Skip to the page

Data / Form D filings / CARLSMED, INC.

CARLSMED, INC.: Form D filings

CARLSMED, INC., a company in Carlsbad, CA, filed 6 Form D notices with the SEC between 2019 and 2025. The latest, on February 7, 2025, reports $64.5 million sold of a $64.5 million offering to 7 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1800 ASTON AVENUE, SUITE 100, Carlsbad, CA, 92008
Phone
(858) 295-9290
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1794546

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 7, 2025Amendment$64,499,995$64,499,9957Mar 12, 2024sec.gov
Mar 21, 2024New notice$52,499,996$38,499,996$14,000,0006Mar 12, 2024sec.gov
Apr 27, 2022New notice$29,999,990$29,999,99021Apr 18, 2022sec.gov
Dec 17, 2020New notice$12,643,855$12,634,480$9,37550Dec 15, 2020sec.gov
May 15, 2020Amendment$2,485,000$1,985,000$500,00040Nov 4, 2019sec.gov
Nov 19, 2019New notice$1,500,000$475,000$1,025,00012Nov 4, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Robert MittendorffDirector
Kevin O'BoyleDirector
Leonard GreensteinExecutive Officer
Durall ScottExecutive Officer
Niall CaseyExecutive Officer, Director
Philip YoungDirector
Michael CordonnierExecutive Officer, Director
Kevin SidowDirector
Sharon SchulzkiExecutive Officer
Shariq HussainExecutive Officer
Jonathan RootDirector

Other companies in California that filed recently

Every Form D from the week of Feb 3, 2025 · All recent filings in California · All recent Other filings

Read from SEC EDGAR. Amount sold is what CARLSMED, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.